Akebia Therapeutics, Inc. (AKBA) › Shares OutstandingAkebia Therapeutics, Inc. (AKBA) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2013: 1.38M2014: 20.37M2015: 30.66M2016: 38.62M2017: 47.61M2018: 116.89M2019: 121.67M2020: 148.07M2021: 177.00M2022: 184.14M2023: 194.58M2024: 224.85M2025: 265.42M265.42M2013Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY2025265.42M+18.0%2024224.85M+15.6%2023194.58M+5.7%2022184.14M+4.0%2021177.00M+19.5%2020148.07M+21.7%2019121.67M+4.1%2018116.89M+145.5%201747.61M+23.3%201638.62M+25.9%201530.66M+50.5%201420.37M+1372.6%20131.38M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share